Ollin Biosciences

Austin, United States

Ollin Biosciences operates as a clinical-stage biopharmaceutical company.

$100.0M raised

Sep 2025

Series A

Biopharma Medical Therapeutics

Top Investors

ARCH Venture PartnersMubadala CapitalMonograph Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ollin Biosciences

How much funding has Ollin Biosciences raised?

Ollin Biosciences has raised $100.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.

Who are Ollin Biosciences's investors?

Ollin Biosciences's investors include ARCH Venture Partners, Mubadala Capital, Monograph Capital.

Where is Ollin Biosciences headquartered?

Ollin Biosciences is headquartered in Austin, United States.

What does Ollin Biosciences do?

Ollin Biosciences operates as a clinical-stage biopharmaceutical company.

What stage is Ollin Biosciences at?

Ollin Biosciences is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 17, 2025.

MLA

"Ollin Biosciences — Funding & Investors." VCBacked, September 17, 2025, https://www.vcbacked.co/company/ollin-biosciences. Accessed June 4, 2026.

APA

VCBacked. (2025). Ollin Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/ollin-biosciences

Wikipedia (cite web)

{{cite web |title=Ollin Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/ollin-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 17, 2025.

Similar Companies in Biopharma